Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
The Oncologist|December 16, 2017
Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine TumorsRamon Salazar, Rocio Garcia-Carbonero, Steven K Libutti, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 24, 2018
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world studyMaria Rinzivillo, Nicola Fazio, Sara Pusceddu, et al.
The New England Journal of Medicine|July 25, 2008
Sorafenib in advanced hepatocellular carcinomaJosep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, et al.
Advances in Therapy|November 23, 2016
Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS)Sebastiano Mercadante, Paolo Marchetti, Arturo Cuomo, et al.
Cancers|June 6, 2018
Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer PatientsSebastiano Mercadante, Paolo Marchetti, Arturo Cuomo, et al.
JCO Precision Oncology|December 7, 2020
Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS StudyFrancesco Pantano, Paolo Manca, Grazia Armento, et al.
Gastroenterology|April 16, 2018
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin AnaloguesSara Pusceddu, Claudio Vernieri, Massimo Di Maio, et al.
Pageof 5